Vaccine Watch: European Union gives emergency approval to Moderna COVID-19 vaccine
The vaccine makes use of the mRNA platform like Pfizer’s vaccine, which the EU has already approved for emergency use
Moderna strikes with a new lawsuit
Moderna is trying to be gatekeeper for the mRNA platform for future drug development, raising monopolistic fears
Bizarre patent tussles over a COVID-19 jab
Moderna’s many intellectual property disputes over its vaccine highlight the need for a patent-free regime to fight the pandemic
Moderna claims 94% efficacy for its COVID-19 vaccine, to seek emergency nod
No Indian partner yet for production or distribution; results not final
Bharat Biotech COVID-19 vaccine claimed to have 80.6% efficacy
'Shot well tolerated in participants; adverse events balanced between vaccine and placebo arms of the trial'
COVID-19 vaccines: Is foreign good for India
The decision to allow foreign vaccines in India may not take plug the current shortage
Pandemic treaty: Draft urges cooperation, equity, transparency but misses independent monitoring
Draft has evolved from a working document circulated earlier this year in July and builds on the comments made by member states, domain experts …
How drug companies are sidestepping the WHO’s technology transfer hub in Africa
The actions of BioNTech and Moderna will prolong the social and economic costs of the pandemic
Pfizer wants to sell vaccines in India at no profit
The Pfizer vaccine is yet to be registered in India although it had applied months ago
India readies for COVID-19 vaccination but vexed questions on the solution remain
The risks the country needs to prepare for, precautions it needs to take, the logistics required and, above all, the implications of it all for …
Update COVID-19 vaccine to target omicron variants: Advisory panel to USFDA
Unclear which combination of updated vaccine will work best; body expected to decide by July
COVID-19: J&J vaccine can heighten risk of rare neurological condition
The Guillain-Barré syndrome can cause muscle weakness and paralysis.
COVID-19 Vaccine Watch: India tops number of COVID-19 vaccine doses arranged from manufacturers
However, in terms of the proportion of the population that can be vaccinated with these doses, Canada leads the charts
Effectiveness of COVID-19 vaccines against infection, severe disease declined with new variants; here's how
AstraZeneca vaccine provided least protection against infection, showed most rapid decline
WATCH: Will mixing COVID-19 vaccines be effective?
Some early studies have shown that combining vaccines produce a better immune response. But the efficacy of the vaccine combination is yet to be …
COVID-19 vaccines for all: Decoding global tenders by states
At least a dozen Indian states have floated or will float tenders for procuring vaccines and will also bear the cost
COVID-19 vaccines: How Pfizer and Moderna’s 95% effective mRNA shots work
Should we expect the pandemic to be over once a vaccine is available for public use? Not exactly. A vaccine will not be perfect, and it takes …
Moderna’s COVID vaccine reports 95% efficacy. It means we might have multiple successful vaccines
It opens the door to the possibility we might have many successful vaccines, and be able to tailor different vaccines to people with different needs
Covaxin effective against UK Strain: What does this mean in absence of efficacy data?
Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts
WTO decision on access to COVID-19 drugs without strings delayed
Proposal will be formally discussed in March next year, sources say
COVID-19 vaccine: Oxford-AstraZeneca up to 90% effective in late stage trial
Adenovirus vaccine can be stored at 2-8°C; company to apply for emergency authorisation
Experts suggest updating vaccines for new variants. How does it work & what are the challenges?
It is easier to update certain vaccine platforms than others, say experts
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …
What COVID-19 vaccine side effects might I expect?
In the vast majority of cases, any side effect you feel will be over within a few days, and there is no reason for concern
UK, South African, Brazilian: A virologist explains each COVID-19 variant, what they mean for the pandemic
The take-home message is that variants will emerge, and we need to closely monitor their spread